Willis Towers Watson PLC Form 8.1(a) -- Willis Towers Watson plc (2106M)
19 Enero 2021 - 9:30AM
UK Regulatory
TIDM0Y4Q
RNS Number : 2106M
Willis Towers Watson PLC
19 January 2021
Ap9
APPENDIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
1. KEY INFORMATION
Name of person dealing John Haley
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 12 January 2021
================================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ====== =========== ======
(1) Relevant securities Ordinary Shares:
124,927 (0.097%)
===================== ===================
(2) Derivatives (other N/A
than options)
===================== ===================
(3) Options and agreements Restricted share
to purchase/sell units ("RSUs")
pursuant to Willis
Towers Watson
Non-Qualified
Deferred Savings
Plan for U.S.
Employees: 109,649
(0.085%)
===================== ===================
Total 234,576 (0.182%)
===================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant Long Short
security:
====
Number (%) Number (%)
=================== ========== ================= ====
(1) Relevant securities N/A
=============================== =================
N/A
(2) Derivatives
(other than options)
=============================== =================
Options: 150,235 (0.116%)
(3) Options and
agreements to purchase/sell Vested WTW Shares that
will settle upon termination
of service: 274,134
(0.213%)
2020 long-term incentive
performance based RSU
award (unearned): 47,374
(0.037%)
2019 long term- incentive
performance based RSU
award (unearned): 53,996
(0.042%)
Dividend equivalent
rights accrued on ordinary
shares earned under
performance based RSU
award: 6,613 (0.005%)
RSUs under the Willis
Towers Watson Non-Qualified
Stable Value Excess
Plan for U.S. Employees:
13,560 (0.011%)
=============================== =================
Total 545,912 (0.423%)
=============================== =================
Ap10
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, Expiry Option
e.g. call selling, securities price e.g. American, date money paid/received
option purchasing, to which European per unit
varying the option etc. (Note 5)
etc. relates (Note
7)
RSUs pursuant
to a deferral
under the
Willis Towers
Watson Non-Qualified
Deferred Savings
Plan for U.S. Accrual
Employees of RSUs 90 N/A N/A N/A $199.95
============== =============== ========= ================ ====== =====================
RSUs pursuant
to an allocation
under the
Willis Towers
Watson Non-Qualified
Deferred Savings
Plan for U.S. Accrual
Employees of RSUs 52 N/A N/A N/A $0
============== =============== ========= ================ ====== =====================
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and
any other person relating to the voting rights of any relevant
securities under any option referred to
on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
N/A
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 19 January 2021
Contact name Cindy Hanna
=========================
Telephone number +1 (212) 915-7994
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEGPUWAGUPGGCB
(END) Dow Jones Newswires
January 19, 2021 10:30 ET (15:30 GMT)
Willis Towers Watson (LSE:0Y4Q)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Willis Towers Watson (LSE:0Y4Q)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024